Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Norway / NCT02939612
Active, not recruiting Not applicable

Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial

NCT02939612 · tracked via the Priya Life Science Norway tracker
Sponsor
Oslo University Hospital
Phase
Not applicable
Started
2016-10
Last updated
2025-03-20

Condition(s) studied

CancerStress, Psychological

Investigational drug(s) / intervention(s)

App for stress management

App for stress management: An app consisting of 10 modules that teaches stress management, cognitive behavioral coping skills and relaxation training.

Study summary

The purpose with this study is to test the effect of an app for stress management among patients with a variety of cancer diagnoses.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients diagnosed with cancer (all diagnosis). * Maximum time since completed treatment at hospital: 12 months * Patients are \> 18 years of age, able to write/read/speak Norwegian and have their own smart phone or tablet Exclusion Criteria: • None

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Oslo University hospital Oslo Norway

More Oslo University Hospital trials in Norway

Early Discovery of Ischemia After Replantation Surgery of the Extremities Active, not recruiting
Anal Cancer Radiotherapy Study Active, not recruiting
RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck Active, not recruiting
A Study of Enalapril in Treatment of Venous Malformations Recruiting
Treatment of Olecranon Fractures in the Elderly Recruiting

Other trials for the same condition

Digital Intervention Targeting Cancer-related Cognitive Impairments Starting soon
Pan Tumor Rollover Study Recruiting
Psychoeducational Course for Suicide Prevention Recruiting
Tailored Health Literacy Follow-up in Cancer Recruiting
Effects of Oncological Treatment During Pregnancy on Mother and Child Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02939612 on ClinicalTrials.gov ↗ ← All trials in Norway